ArticlemedRxiv : the preprint server for health sciences2020

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study.

Edward E Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.